These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2313850)

  • 1. Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.
    Scott HD; Thacher-Renshaw A; Rosenbaum SE; Waters WJ; Green M; Andrews LG; Faich GA
    JAMA; 1990 Apr; 263(13):1785-8. PubMed ID: 2313850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reaction reporting systems: the United Kingdom and the United States.
    Scott HD; Thacher A; Rosenbaum SE; Waters WJ; Green M
    R I Med J (1976); 1988 May; 71(5):179-84. PubMed ID: 3387803
    [No Abstract]   [Full Text] [Related]  

  • 3. National adverse drug reaction reporting. 1984-1989.
    Faich GA
    Arch Intern Med; 1991 Aug; 151(8):1645-7. PubMed ID: 1872669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician knowledge, attitudes, and behavior related to reporting adverse drug events.
    Rogers AS; Israel E; Smith CR; Levine D; McBean AM; Valente C; Faich G
    Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhode Island physicians' recognition and reporting of adverse drug reactions.
    Scott HD; Rosenbaum SE; Waters WJ; Colt AM; Andrews LG; Juergens JP; Faich GA
    R I Med J (1976); 1987 Jul; 70(7):311-6. PubMed ID: 3476980
    [No Abstract]   [Full Text] [Related]  

  • 7. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists.
    Generali JA; Danish MA; Rosenbaum SE
    Ann Pharmacother; 1995 Apr; 29(4):365-9. PubMed ID: 7633012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National adverse drug reaction surveillance: 1985.
    Faich GA; Knapp D; Dreis M; Turner W
    JAMA; 1987 Apr; 257(15):2068-70. PubMed ID: 3560382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physician attitudes toward the reporting of adverse drug reactions on the Pomeranian region].
    Schetz D; Sein Anand J
    Przegl Lek; 2015; 72(9):475-8. PubMed ID: 26827571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions and reporting.
    Witte R
    Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating the completeness and accuracy of MedWatch data.
    Getz KA; Stergiopoulos S; Kaitin KI
    Am J Ther; 2014; 21(6):442-6. PubMed ID: 23011177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
    Figueiras A; Herdeiro MT; Polónia J; Gestal-Otero JJ
    JAMA; 2006 Sep; 296(9):1086-93. PubMed ID: 16954488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food and Drug Administration monitoring of adverse drug reactions.
    Sills JM; Tanner LA; Milstien JB
    Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of electronic health record implementation: a statewide survey of physicians in Rhode Island.
    Wylie MC; Baier RR; Gardner RL
    Am J Med; 2014 Oct; 127(10):1010.e21-7. PubMed ID: 24945882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug makers' adverse event reports are often incomplete, US report finds.
    McCarthy M
    BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561
    [No Abstract]   [Full Text] [Related]  

  • 18. Reporting drug side effects: signals and noise.
    Avorn J
    JAMA; 1990 Apr; 263(13):1823. PubMed ID: 2313853
    [No Abstract]   [Full Text] [Related]  

  • 19. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward improved adverse event/suspected adverse drug reaction reporting.
    Gross R; Strom BL
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):89-91. PubMed ID: 12642971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.